Lipid control and stroke risk in atrial fibrillation patients treated with direct oral anticoagulants and statins.

Ip, Bonaventure; Yip, Terry; Hung, Trista; Yam, Tsz-Fai; Yeung, Carly; Ko, Ho; Wong, Grace; Leng, Xinyi; Mok, Vincent; Soo, Yannie; Seiffge, David; Shoamanesh, Ashkan; Leung, Thomas (2024). Lipid control and stroke risk in atrial fibrillation patients treated with direct oral anticoagulants and statins. (In Press). European stroke journal, 23969873241272530, p. 23969873241272530. Sage 10.1177/23969873241272530

Text ip-et-al-2024-lipid-control-and-stroke-risk-in-atrial-fibrillation-patients-treated-with-direct-oral-anticoagulants-and.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB)

INTRODUCTION

The risk of ischemic stroke and intracerebral hemorrhage (ICH) with intensive lipid control by statins among patients with atrial fibrillation (AF) who require direct oral anticoagulants (DOAC) is unclear. We aimed to determine the risks of ischemic stroke and ICH in AF patients treated with DOAC and statins.

PATIENTS AND METHODS

In a population-based retrospective cohort study, we identified AF patients concurrently on DOAC and statins from 2015 to 2021 in Hong Kong. Primary outcome was ischemic stroke. Secondary outcomes were ICH and death. We correlated study outcomes with low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) as time-varying, continuous variables with restricted cubic spline. In secondary analyses, the risks of study outcomes with statin intensity (low, moderate, high) were determined by multivariable time-dependent marginal structural Cox models.

RESULTS

We identified 32,752 AF patients co-prescribed with DOAC and statins. Lower LDL-C (p < 0.001) and higher HDL-C (p < 0.001) levels were associated with lower risk of ischemic stroke but not significantly associated with ICH. LDL-C of <1.8 mmol/L (70 mg/dL) was not associated with mortality (19.6% vs 18.4%, difference 1.2% [95% CI -0.35 to 2.13]). High-intensity statin was associated with a lower risk of ischemic stroke compared with low-intensity statin (weighted Cox-specific hazard ratio [95% CI]: 0.82 [0.67-0.99], p = 0.040) independent of LDL-C levels. Similar associations were found in 11,444 AF patients with a history of ischemic stroke.

DISCUSSION AND CONCLUSION

Intensive lipid control by high-intensity statins was associated with a lower risk of ischemic stroke in AF patients who required DOACs and did not appear to increase the risk of ICH.

Interest & Impact

Downloads

0 since deposited on 20 Aug 2024
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item